Report for Hye Khan MA

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Multitarget molecule,PTUPB, to treat diabetic nephropathy in rats - Hye_2021_Br.J.Pharmacol_178_4468
Author(s) : Hye Khan MA , Hwang SH , Barnett SD , Stavniichuk A , Jankiewicz WK , Hammock BD , Imig JD
Ref : British Journal of Pharmacology , 178 :4468 , 2021
Abstract : Hye_2021_Br.J.Pharmacol_178_4468
ESTHER : Hye_2021_Br.J.Pharmacol_178_4468
PubMedSearch : Hye_2021_Br.J.Pharmacol_178_4468
PubMedID: 34255857

Title : Dual Soluble Epoxide Hydrolase Inhibitor\/PPAR-gamma Agonist Attenuates Renal Fibrosis - Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
Author(s) : Stavniichuk A , Hye Khan MA , Yeboah MM , Chesnik MA , Jankiewicz WK , Hartmann M , Blocher R , Kircher T , Savchuk O , Proschak E , Imig JD
Ref : Prostaglandins Other Lipid Mediat , :106472 , 2020
Abstract : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
ESTHER : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
PubMedSearch : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472
PubMedID: 32569747

Title : A dual farnesoid X receptor\/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice - Hye_2019_Biochem.Pharmacol_166_212
Author(s) : Hye Khan MA , Schmidt J , Stavniichuk A , Imig JD , Merk D
Ref : Biochemical Pharmacology , 166 :212 , 2019
Abstract : Hye_2019_Biochem.Pharmacol_166_212
ESTHER : Hye_2019_Biochem.Pharmacol_166_212
PubMedSearch : Hye_2019_Biochem.Pharmacol_166_212
PubMedID: 31129048